Ami Organics Limited
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more
Ami Organics Limited (AMIORG) - Total Liabilities
Latest total liabilities as of March 2025: ₹2.29 Billion INR
Based on the latest financial reports, Ami Organics Limited (AMIORG) has total liabilities worth ₹2.29 Billion INR as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ami Organics Limited - Total Liabilities Trend (2014–2025)
This chart illustrates how Ami Organics Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ami Organics Limited Competitors by Total Liabilities
The table below lists competitors of Ami Organics Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shangri-La Asia Limited
PINK:SHALF
|
USA | $8.88 Billion |
|
Vestis Corporation
NYSE:VSTS
|
USA | $2.15 Billion |
|
Gudeng Precision Industrial Co Ltd
TWO:3680
|
Taiwan | NT$11.21 Billion |
|
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
|
Denmark | Dkr30.11 Billion |
|
Jilin Liyuan Precision Manufacturing Co Ltd
SHE:002501
|
China | CN¥720.23 Million |
|
Iperionx Ltd
AU:IPX
|
Australia | AU$12.59 Million |
|
Surgery Partners Inc
NASDAQ:SGRY
|
USA | $4.39 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Ami Organics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ami Organics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ami Organics Limited (2014–2025)
The table below shows the annual total liabilities of Ami Organics Limited from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹2.29 Billion | -44.53% |
| 2024-03-31 | ₹4.13 Billion | +138.84% |
| 2023-03-31 | ₹1.73 Billion | +26.62% |
| 2022-03-31 | ₹1.37 Billion | -44.54% |
| 2021-03-31 | ₹2.46 Billion | +105.15% |
| 2020-03-31 | ₹1.20 Billion | -8.29% |
| 2019-03-31 | ₹1.31 Billion | +33.76% |
| 2018-03-31 | ₹978.86 Million | +39.68% |
| 2017-03-31 | ₹700.79 Million | +7.87% |
| 2016-03-31 | ₹649.65 Million | +46.40% |
| 2015-03-31 | ₹443.74 Million | +58.84% |
| 2014-03-31 | ₹279.37 Million | -- |